ActiveRADAR Therapeutic Alternative Service and Value-Based Reimbursement Programs Now Includes 86 Therapeutic Classes.

At its February P&T Committee meeting, ActiveRADAR added Biologic Immunomodulators and 5 other drug classes to its list of Therapeutic Alternatives Service (AR-TAS) and Value-based Reimbursement program.  In addition to the specialty drug products used for managing autoimmune conditions like rheumatoid arthritis, inflammatory bowel disease and psoriasis, ActiveRADAR added five other drug classes / health condition categories including Actinic Keratosis, PCSK-9 inhibitors, Viscosupplements, Erythroid Stimulants and Atopic Dermatitis drugs. ActiveRADAR’s Therapeutic Alternatives Service (AR-TAS) delivers formulary-specific and medically accepted use specific therapeutic alternatives for 86 therapeutic drug classes along with corresponding dosage strengths, quantities, and plan-specific member and plan costs (net of discounts).